用L-氨酸修饰的纳米酶向M1巨细胞,用于口腔治疗性结肠炎
Shuaiwen Li1, Zihui Chen1, Minyu Wang2
1Department of Chemistry, Key Laboratory of Biomedical Functional Materials, School of Science, China Pharmaceutical University, Nanjing, 211198, P. R. China.
Small (Weinheim an der Bergstrasse, Germany)
|January 7, 2025
概括
这项研究开发了一种向纳米酶 (Se-CA) 用于性结肠炎 (UC) 治疗. Se-CA有效地减少了肠道的炎症和氧化应激,为UC患者提供了一个有前途的新疗法.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 胃肠病学 胃肠病学
背景情况:
- 性结肠炎 (UC) 的特点是慢性结肠炎症和氧化应激.
- 过度反应性氧物种 (ROS) 损害肠道细胞并改变微生物群,加剧UC.
- 目前针对UC的抗氧化疗法缺乏肠道稳定性和向性输送.
研究的目的:
- 开发一种针对性口服纳米酶治疗性结肠炎 (UC) 的方法.
- 为了研究L-氨酸修饰的纳米酶 (Se-CA) 在治疗UC的疗效.
- 评估Se-CA向M1型巨细胞和减轻氧化损伤的能力.
主要方法:
- 合成L-氨酸修饰的纳米酶 (Se-CA).
- 在实验室中评估Se-CA在模拟肠道条件下的抗氧化和抗ferroptosis活性.
- 在性结肠炎小鼠模型中对Se-CA的体内评估.
主要成果:
- 在实验室中,Se-CA证明了有效的ROS和反应性物种 (RNS) 清理.
- 在肠道上皮细胞中,Se-CA抑制了铁死亡.
- 在大肠炎小鼠模型中,口服Se-CA显示出显著的抗炎和抗氧化作用,改善了肠道屏障功能,并调节了肠道微生物群.
结论:
- 用L-氨酸修饰的纳米酶 (Se-CA) 提供了针对性和有效的口服治疗性结肠炎的策略.
- Se-CA能够准M1巨细胞并对抗氧化应激是一种新的治疗方法.
- 这项研究为开发针对炎症性肠道疾病的基于纳米酶的先进疗法提供了基础.
更多相关视频
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
10.0K
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
811
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
378
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
378
01:26Peptic Ulcer Disease IV: Management
72
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
72